Medroxyprogesteron acetate use to block LH surge in oocyte donor stimulation

Česká verze

Authors: I. Crha ^1,2 ; P. Ventruba ¹; E. Filipinská ¹; M. Dziakova ¹; J. Žáková ¹; M. Ješeta ¹; E. Lousová ¹; Z. Papíková ¹
Authors place of work: Gynekologicko-porodnická klinika LF MU a FN, Brno, přednosta prof. MUDr. P. Ventruba, DrSc., MBA ¹; Katedra porodní asistence a zdravotnických záchranářů LF MU, Brno, přednosta doc. MUDr. I. Crha, CSc. ²
Published in the journal: Ceska Gynekol 2018; 83(1): 11-16

Summary

Objective:
To compare the results of ovarian stimulation with LH surge blockade by medroxyprogesterone acetate or GnRH antagonist in oocytes donors. To present current options of exogenous and endogenous progestins instead of GnRH analogues to block LH surge during ovarian stimulation.

Design:
Retrospective study of oocyte donor cycles and literature review.

Setting:
Department of Obstetrics and Gynecology, Faculty of Medicine, Masaryk university and University Hospital Brno.

Methods:
Thirteen oocyte donors (26.8 ± 2.5 years old) were stimulated with recFSH and MPA to block the LH surge during January – October 2017. The results were compared to the previous cycle stimulated with recFSH and GnRH antagonist performed during January –December 2016. Wilcoxon´s pair test was used to test the statistics. A literature search of SCOPUS was carried out.

Results:
In cycles with MPA blockade the average number of oocytes was 14.5 ± 5.1, in cycles with GnRH antagonist blockade 12.0 ± 4.5 oocytes (statistical significance p = 0.025). FSH total dose (1611 ± 327 vs. 1565 ± 322 IU), days of stimulation (9.1 ± 0.8 vs. 8.5 ± 0.9) and maximum estradiol levels (5.9 ± 2.1 vs. 6.0 ± 3.0 nmol/l) were not statistically different.

Progestins are effective in blocking the LH surge during ovarian stimulation and do not affect the number and quality of collected oocytes or obtained embryos. Their adverse effect on the endometrial receptivity obstructs the embryo implantation in the same cycle. Such protocol requires total freezing and delayed transfer. Progestins can be used in a variety of stimulation protocols – progestin primed follicular phase stimulation, luteal phase stimulation with endogenous progesteron, double stimulation in follicular and luteal phase of the same cycle „duostim“ in low responders.

Conclusion:
Eggs donor ovarian stimulation with MPA resulted in more oocytes than stimulation protocol with GnRH antagonist, the total dose of FSH and the length of stimulation were similar. According to current experiences progestins effectively block the LH surge and do not affect the number and quality of collected eggs and obtained embryos. Their use opens new possibilities of ovarian stimulation protocols and their flexibility. Its main constraint is that it requires total freezing and delayed transfer.

Keywords:
ovarian stimulation, progestins, medroxyprogesterone acetate, oocyte donation, LH block, luteal phase stimulation

Zdroje

1. Argyle, CE., Harper, JC., Davies, MC. Oocyte cryopreservation: where are we now? Hum Reprod Update, 2016, 22(4), p. 440–449.

2. Baerwald, AR., Adams, GP., Pierson, RA. A new model for ovarian follicular development during the human menstrual cycle. Fertil Steril, 2003, 80, p. 116–122.

3. Buendgen, NK., Schultze-Mosgau, A., Cordes, T., et al. Initiation of ovarian stimulation independent of the menstrual cycle: a case-control study. Arch Gynecol Obstet, 2013, 288, p. 901–904.

4. Gougeon, A. Dynamics of follicular growth in the human: a model from preliminary results. Hum Reprod, 1986, 1(2), p. 81–87.

5. Halászová, N., Crha, I., Huser, M., et al. Zachování fertility u žen s karcinomem prsu před gonadotoxickou léčbou. Čes Gynek, 2017, 82(4), s. 287–292.

6. Hens, K., Dondorp, W., Handyside, AH., et al. Dynamics and ethics of comprehensive preimplantation genetic testing: a review of the challenges. Hum Reprod Update, 2013, 19(4), p. 366–375.

7. Huser, M. Onkofertilita – nová oblast reprodukční medicíny. 1.ed. Praha: Mladá fronta, 2014, 109 s.

8. Huser, M., Smardova, L., Janku, P., et al. Fertility status of Hodgkin lymphoma patients treated with chemotherapy and adjuvant gonadotropin-releasing hormone analogues. J Assist Reprod Genet, 2015, 32(8), p. 1187–1193.

9. Křepelka, P. Hormonální antikoncepce – zásady bezpečné praxe. Praha: Mladá fronta, 2013, 284 s.

10. Kuang, Y., Chen, Q., Fu, Y., et al. Medroxyprogesterone acetate is an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in vitro fertilization. Fertil Steril, 2015, 104, p. 62–70.

11. Kuang, Y., Chen, Q., Hong, Q., et al. Double stimulations during the follicular and luteal phases of poor responders in IVF/ICSI programmes (Shanghai protocol). Reprod Biomed Online, 2014, 29, p. 684–691.

12. Maman, E., Meirow, D., Brengauz, M., et al. Luteal phase oocyte retrieval and in vitro maturation is an optional procedure for urgent fertility preservation. Fertil Steril, 2011, 95, p. 64–67.

13. Messinis, IE., Messini, CI., Dafopoulos, K. Novel aspects of the endocrinology of the menstrual cycle. Reprod Biomed Online, 2014, 28, p.714–722.

14. Roque, M., Valle, M., Guimarães, F., et al. Freeze-all policy: fresh vs. frozen-thawed embryo transfer. Fertil Steril, 2015, 103, p. 1190–1193.

15. Rumpíková, T., Oborná, I., Konečná, H. Současné trendy v psychosociální a etické problematice dárcovství gamet. Čes Gynek, 2017, 82(4), s. 293–299.

16. Ubaldi, FM., Capalbo, A., Vaiarelli, A., et al. Follicular versus luteal phase ovarian stimulation during the same menstrual cycle (DuoStim) in a reduced ovarian reserve population results in a similar euploid blastocyst formation rate: new insight in ovarian reserve exploitation. Fertil Steril, 2016, 105(6), p. 1488–1495.

17. Ventruba, P., Žáková, J., Trávník, P., et al. Aktuální otázky asistované reprodukce v České republice. Čes Gynek, 2013, 78(4), s. 392–398.

18. Wang, N., Wang, Y., Chen, Q., et al. Luteal phase ovarian stimulation vs conventional ovarian stimulation in patients with normal ovarian reserve treated for IVF: a large retrospective cohort study. Clin Endocrinol, 2016, 84, p. 720–728.

19. Zhu, X., Ye, H., Fu, Y. Duphaston and human menopausal gonadotropin protocol in normally ovulatory women undergoing controlled ovarian hyperstimulation during in vitro fertilization/intracytoplasmic sperm injection treatments in combination with embryo cryopreservation. Fertil Steril, 2017, 108(3), p. 505–512.